Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter P Wibroe

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Advanced Drug Delivery Reviews|May 29, 2012
Perspectives on carbon nanotube-mediated adverse immune effectsAlina J Andersen, Peter P Wibroe, S Moein Moghimi
Microbiology Spectrum|June 25, 2015
The Role of Complement in Antibody Therapy for Infectious DiseasesPeter P Wibroe, Shen Y Helvig, S Moein Moghimi
Maturitas|June 20, 2012
Polymeric particulate technologies for oral drug delivery and targeting: a pathophysiological perspectiveA Christy Hunter, Jacqueline Elsom, Peter P Wibroe, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|August 1, 2012
Polymeric particulate technologies for oral drug delivery and targeting: a pathophysiological perspectiveA Christy Hunter, Jacqueline Elsom, Peter P Wibroe, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 27, 2015
An integrated assessment of morphology, size, and complement activation of the PEGylated liposomal doxorubicin products Doxil®, Caelyx®, DOXOrubicin, and SinaDoxosomePeter P Wibroe, Davoud Ahmadvand, Mohammad Ali Oghabian, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|September 9, 2015
Citrem modulates internal nanostructure of glyceryl monooleate dispersions and bypasses complement activation: Towards development of safe tunable intravenous lipid nanocarriersPeter P Wibroe, Intan D Mat Azmi, Christa Nilsson, et al.
Biomaterials|December 10, 2015
Soluble and immobilized graphene oxide activates complement system differently dependent on surface oxidation statePeter P Wibroe, Søren V Petersen, Nicolas Bovet, et al.
Advanced Drug Delivery Reviews|May 29, 2012
Genomic perspectives in inter-individual adverse responses following nanomedicine administration: The way forwardS Moein Moghimi, Peter P Wibroe, Shen Y Helvig, et al.
Advanced Drug Delivery Reviews|June 22, 2011
Material properties in complement activationS Moein Moghimi, Alina J Andersen, Davoud Ahmadvand, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|June 15, 2013
Structural profiling and biological performance of phospholipid-hyaluronan functionalized single-walled carbon nanotubesRam Dvash, Artium Khatchatouriants, Leonardo J Solmesky, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Advanced Drug Delivery Reviews|May 29, 2012
Perspectives on carbon nanotube-mediated adverse immune effectsAlina J Andersen, Peter P Wibroe, S Moein Moghimi
Microbiology Spectrum|June 25, 2015
The Role of Complement in Antibody Therapy for Infectious DiseasesPeter P Wibroe, Shen Y Helvig, S Moein Moghimi
Maturitas|June 20, 2012
Polymeric particulate technologies for oral drug delivery and targeting: a pathophysiological perspectiveA Christy Hunter, Jacqueline Elsom, Peter P Wibroe, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|August 1, 2012
Polymeric particulate technologies for oral drug delivery and targeting: a pathophysiological perspectiveA Christy Hunter, Jacqueline Elsom, Peter P Wibroe, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 27, 2015
An integrated assessment of morphology, size, and complement activation of the PEGylated liposomal doxorubicin products Doxil®, Caelyx®, DOXOrubicin, and SinaDoxosomePeter P Wibroe, Davoud Ahmadvand, Mohammad Ali Oghabian, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|September 9, 2015
Citrem modulates internal nanostructure of glyceryl monooleate dispersions and bypasses complement activation: Towards development of safe tunable intravenous lipid nanocarriersPeter P Wibroe, Intan D Mat Azmi, Christa Nilsson, et al.
Biomaterials|December 10, 2015
Soluble and immobilized graphene oxide activates complement system differently dependent on surface oxidation statePeter P Wibroe, Søren V Petersen, Nicolas Bovet, et al.
Advanced Drug Delivery Reviews|May 29, 2012
Genomic perspectives in inter-individual adverse responses following nanomedicine administration: The way forwardS Moein Moghimi, Peter P Wibroe, Shen Y Helvig, et al.
Advanced Drug Delivery Reviews|June 22, 2011
Material properties in complement activationS Moein Moghimi, Alina J Andersen, Davoud Ahmadvand, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|June 15, 2013
Structural profiling and biological performance of phospholipid-hyaluronan functionalized single-walled carbon nanotubesRam Dvash, Artium Khatchatouriants, Leonardo J Solmesky, et al.
Pageof 2